A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States

Since 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested f...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mary Cabell Jonas, Kevin Rubenstein, Eric Watson, Sundeep Basra, Michael Horberg
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	HCV screening usual-care testing non-standardized testing KPMAS HCV treatment Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/51176b019c8e4a23abe61eab2f90dedf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:51176b019c8e4a23abe61eab2f90dedf
record_format	dspace
spelling	oai:doaj.org-article:51176b019c8e4a23abe61eab2f90dedf2021-11-25T19:12:38ZA Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States10.3390/v131121401999-4915https://doaj.org/article/51176b019c8e4a23abe61eab2f90dedf2021-10-01T00:00:00Zhttps://www.mdpi.com/1999-4915/13/11/2140https://doaj.org/toc/1999-4915Since 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested for HCV through usual care versus a coordinator-supported program (HCV pathway) during 2015−2018 within Kaiser Permanente Mid-Atlantic States (KPMAS). In total, 131,176 patients were tested through the HCV pathway and 128,311 through usual care (non-standardized testing). Of those tested, 1.6% (HCV pathway) and 0.5% (usual care) had chronic HCV. Of those with chronic HCV, more patients tested within the HCV pathway completed hepatic transient elastography (82.6% HCV pathway vs. 45.6% usual care; <i>p</i> < 0.001) and a gastroenterology visit (72.2% HCV pathway vs. 46.5% usual care; <i>p</i> < 0.001), and had filled prescriptions for treatment (56.5% HCV pathway vs. 40.3% usual care; <i>p</i> < 0.001). The median time to complete each step was shorter for those tested through the HCV pathway (hepatic transient elastography (26 vs. 118 days), gastroenterology visit (63 vs. 131 days), and prescription fill (222 vs. 326 days)). More patients tested through a coordinator-supported, standardized testing pathway completed the necessary testing steps, in less time, compared to usual care. These findings may inform institutions seeking to create effective population-wide testing programs for HCV and other conditions.Mary Cabell JonasKevin RubensteinEric WatsonSundeep BasraMichael HorbergMDPI AGarticleHCVscreeningusual-care testingnon-standardized testingKPMASHCV treatmentMicrobiologyQR1-502ENViruses, Vol 13, Iss 2140, p 2140 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	HCV screening usual-care testing non-standardized testing KPMAS HCV treatment Microbiology QR1-502
spellingShingle	HCV screening usual-care testing non-standardized testing KPMAS HCV treatment Microbiology QR1-502 Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
description	Since 2020, the US Preventive Services Taskforce has recommended expanding hepatitis C virus (HCV) screening to include ages 18−79, in addition to baby boomers (born 1945−1965) and those at-risk for hepatitis C virus. This retrospective cohort analysis compared patients (18 years and above) tested for HCV through usual care versus a coordinator-supported program (HCV pathway) during 2015−2018 within Kaiser Permanente Mid-Atlantic States (KPMAS). In total, 131,176 patients were tested through the HCV pathway and 128,311 through usual care (non-standardized testing). Of those tested, 1.6% (HCV pathway) and 0.5% (usual care) had chronic HCV. Of those with chronic HCV, more patients tested within the HCV pathway completed hepatic transient elastography (82.6% HCV pathway vs. 45.6% usual care; <i>p</i> < 0.001) and a gastroenterology visit (72.2% HCV pathway vs. 46.5% usual care; <i>p</i> < 0.001), and had filled prescriptions for treatment (56.5% HCV pathway vs. 40.3% usual care; <i>p</i> < 0.001). The median time to complete each step was shorter for those tested through the HCV pathway (hepatic transient elastography (26 vs. 118 days), gastroenterology visit (63 vs. 131 days), and prescription fill (222 vs. 326 days)). More patients tested through a coordinator-supported, standardized testing pathway completed the necessary testing steps, in less time, compared to usual care. These findings may inform institutions seeking to create effective population-wide testing programs for HCV and other conditions.
format	article
author	Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg
author_facet	Mary Cabell Jonas Kevin Rubenstein Eric Watson Sundeep Basra Michael Horberg
author_sort	Mary Cabell Jonas
title	A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
title_short	A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
title_full	A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
title_fullStr	A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
title_full_unstemmed	A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
title_sort	comprehensive coordinator supported hepatitis c virus testing and linkage to treatment program at kaiser permanente mid-atlantic states
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/51176b019c8e4a23abe61eab2f90dedf
work_keys_str_mv	AT marycabelljonas acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT kevinrubenstein acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT ericwatson acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT sundeepbasra acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT michaelhorberg acomprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT marycabelljonas comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT kevinrubenstein comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT ericwatson comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT sundeepbasra comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates AT michaelhorberg comprehensivecoordinatorsupportedhepatitiscvirustestingandlinkagetotreatmentprogramatkaiserpermanentemidatlanticstates
_version_	1718410155230494720

A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States

Ejemplares similares